The 22 references in paper E. Chernykh R., O. Leplina Yu., T. Tyrinova V., M. Tikhonova A., V. Stupak V., S. Mishinov V., I. Pendyurin V., A. Ostanin A., Е. Черных Р., О. Леплина Ю., Т. Тыринова В., М. Тихонова А., В. Ступак В., С. Мишинов В., И. Пендюрин В., А. Останин А. (2014) “ПРОТИВООПУХОЛЕВАЯ АКТИВНОСТЬ ДЕНДРИТНЫХ КЛЕТОК ЗДОРОВЫХ ДОНОРОВ И БОЛЬНЫХ С ОПУХОЛЯМИ ГОЛОВНОГО МОЗГА // ANTI-TUMOR ACTIVITY OF DENDRITIC CELLS IN HEALTHY DONORS AND PATIENTS WITH BRAIN TUMORS” / spz:neicon:mimmun:y:2010:i:3:p:199-206

1
Черных Е.Р., Леплина О.Ю., Ступак В.В., Пендюрин И.В., Никонов С.Д., Тихонова М.А., Останин А.А. Клеточные технологии в лечении злокачественных глиом головного мозга // Клеточные технологии. Теоретические и прикладные аспекты. – Новосибирск: Наука, 2009. – С. 240-276.
(check this in PDF content)
2
Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y., Pulendran B., Palucka K. Immunobiology of dendritic cells // Annu Rev Immunol. – 2000. – Vol. 18. – P. 767-811.
(check this in PDF content)
3
Becker Y. Dendritic cell activity against primary tumors: an overview // In Vivo. – 1993. – Vol. 7. – P. 187-191.
(check this in PDF content)
4
Chaperot L., Blum A., Manches O., Lui G., Angel J., Molens J-P., Plumas J. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells // J. Immunol. – 2006. – Vol. 176. – P. 248-255.
(check this in PDF content)
5
Chapoval A.I., Tamada K., Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells // Blood. – 2000. – Vol. 95. – P. 2346-2351.
(check this in PDF content)
6
Chauvin C., Josien R. Dendritic cells as killers: mechanistic aspects and potential roles // J. Immunol. – 2008. – Vol. 18. – P. 11-16.
(check this in PDF content)
7
Della Bella S., Nicola S., Riva A., Biasin M., Clerici M., Villa M.L. Functional repertoire of dendritic cells generated in granulocyte macrophagecolony stimulating factor and interferon-α // J. Leuk Biol. – 2004. – Vol. 75. – P. 106-116.
(check this in PDF content)
8
Ehtesham M.P., Kabos M.A., Gutierrez K., Samoto K.L., Black J., Yu S. Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats //J. Immunother. – 2003. – Vol. 26. – P. 107-116.
(check this in PDF content)
9
Fanger N.A., Maliszewski C.R., Schooley K., Griffith T.S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosisinducing ligand (TRAIL) // J. Exp. Med. – 1999. – Vol. 190. – P. 1155-1164.
(check this in PDF content)
10
Jun S., Ikeda K., Maeda Y., Shinagawa K., Ohtsuka A., Yamamura H., Tanimoto M. Identification of CD123+ myeloid dendritic cells as anearly-stage immature subset with strong tumoristatic potential // Cancer Letters. – 2008. – Vol. 270. – P. 19-29.
(check this in PDF content)
11
Korthals M., Safaian N., Kronenwett R., Maihfer D., Schott M., Papewalis C., BlancoE.D., Winter M., Czibere A., Haas R., Kobbe G., Fenk R. Monocyte derived dendritic cells generated by IFNα acquire mature dendritic and natural killer cell properties as shown by gene expression analysis // J. Translational Med. – 2007. – Vol. 5. – P. 46-57.
(check this in PDF content)
12
Larmonier K., Fraszczak J., Lakomy D., Bonnotte B., Katsanis E. Killer dendritic cells and their potential for cancer immunotherapy // Cancer Immunol & Immunother. – 2009. – Vol. 59. – P. 1-11.
(check this in PDF content)
13
Liu S., Yu Y., Zhang M., Wang W., Cao X. The involvement of TNF-alpha-related apoptosis inducing ligand in the enhanced cytotoxicity of IFN-betastimulated human dendritic cells to tumor cells // J. Immunol. – 2001. – Vol. 166. – P. 5407-5415.
(check this in PDF content)
14
Manna P.P., Mohanakumar T. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro // J. Leuk Biol. – 2002. – Vol. 72. – P. 312-320.
(check this in PDF content)
15
Melief C.J. Cancer immunotherapy by dendritic cells // Immunity. – 2008. – Vol. 29. – P. 372-383.
(check this in PDF content)
16
Santini S., Pucchini T., Lapenta C., Parlato S., Logozzi M., Belardelli F. A new type 1 IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells // Stem cells. – 2003. – Vol. 21. – P. 357-362.
(check this in PDF content)
17
Shin J.Y., Lee C.D. Kang J.S., Chung E., Lee Y., Seo S.Y., Lee S.Y., Baek S.Y., Kim B.S., Kim J.B., Yoon S. Anti-tumor effect of intratumoral administration of dendritic cell combination with vincristine chemotherapy in a murine fibrosarcoma model // Histol. Histopathol. – 2003. – Vol. 18. – P. 435-447.
(check this in PDF content)
18
Tong Y., Song W., Crystal R.G. Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors // Cancer Res. – 2001. – Vol. 61. – P. 7530-7535.
(check this in PDF content)
19
Vanderheyde N., Vandenabeele P., Goldman M., Willems F. Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells // Immunol Lett. – 2004. – Vol. 91. – P. 99-101.
(check this in PDF content)
20
Vidalain P.O., Azocar O., Yagita H., RabourdinCombe C., Servet-Delprat C. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand // J. Immunol. – 2001. – Vol. 167, N 7. – P. 3765-3772.
(check this in PDF content)
21
Wang M., Shi J., Wan Y., Li J., Yuan Y. A subset of myeloid dendritic cells derived from peripheral blood monocytes represented a predominant subset characterized by their potential tumor-inhibiting activity // In Vitro Cell. Dev. Biol.-Animal. – 2009. – Vol. 45. – P. 398-404.
(check this in PDF content)
22
Wesa A.K., Storkus W.J. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer // Cell Death Differ. – 2008. – Vol. 15. – P. 51-57. поступила в редакцию 14.12.2009
(check this in PDF content)